Militia Capital Partners, LP Prelude Therapeutics Inc Transaction History
Militia Capital Partners, LP
- $126 Billion
- Q1 2025
A detailed history of Militia Capital Partners, LP transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Militia Capital Partners, LP holds 4,300 shares of PRLD stock, worth $3,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,300Holding current value
$3,483% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRLD
# of Institutions
57Shares Held
28.3MCall Options Held
23.9KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$8.84 Million0.26% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$8.2 Million0.09% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$865,8210.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$817,4550.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD976KShares$790,6790.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $29.5M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...